Earnings History Data for Annovis Bio (ANVS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Annovis Bio

Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-11-2023 AH ANVS Annovis Bio 57.00 -1.63 -1.10 0.00 Annovis Bio reports Q3 results
[11/8/2023 5:36 PM]
5.80 0.25 
(4.50%)
6.25 0.70 
(12.61%)
5.42 - 23.89 90,152 100,000 1,704
15-08-2023 PM ANVS Annovis Bio, Inc. 118.51 -1.07 -1.14 -1.07 Annovis Bio reports Q2 results
[8/15/2023 7:27 AM]
12.70 -0.46 
(-3.50%)
13.17 0.01 
(0.08%)
10.14 - 23.91 44,840 20,000 106
11-05-2023 PM ANVS Annovis Bio, Inc. 121.61 -1.19 -0.85 -0.72 Annovis Bio reports Q1 results
[5/11/2023 9:19 AM]
14.98 0.02 
(0.13%)
14.99 0.19 
(1.28%)
8.39 - 23.91 32,919 30,000 100
03-04-2023 PM Before the open
(Apr 3)
ANVS Annovis Bio 164.00 -0.38 -1.15 0.00 Annovis Bio reports Q4 results
[4/3/2023 7:35 AM]
11.99 -3.42 
(-22.19%)
13.07 -2.34 
(-15.18%)
8.39 - 23.91 457,355 140,000 34,091
08-11-2022 AH ANVS Annovis Bio 102.00 -0.93 -1.17 0.00 Annovis Bio GAAP EPS of -$0.93 beats by $0.08
[11/8/2022 5:47 PM]
11.85 -0.30 
(-2.47%)
12.13 -0.35 
(-2.80%)
8.39 - 37.60 17,162 20,000 161